During the last session, Edgewise Therapeutics Inc (NASDAQ:EWTX)’s traded shares were 0.68 million, with the beta value of the company hitting 0.21. At the end of the trading day, the stock’s price was $16.17, reflecting an intraday gain of 1.44% or $0.23. The 52-week high for the EWTX share is $20.69, that puts it down -27.95 from that peak though still a striking 68.34% gain since the share price plummeted to a 52-week low of $5.12. The company’s market capitalization is $1.51B, and the average trade volume was 744.33K shares over the past three months.
Edgewise Therapeutics Inc (NASDAQ:EWTX) trade information
Edgewise Therapeutics Inc (EWTX) registered a 1.44% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.44% in intraday trading to $16.17, hitting a weekly high. The stock’s 5-day price performance is 6.17%, and it has moved by -9.97% in 30 days. Based on these gigs, the overall price performance for the year is 104.94%.
Edgewise Therapeutics Inc (EWTX) estimates and forecasts
Statistics show that Edgewise Therapeutics Inc has underperformed its competitors in share price, compared to the industry in which it operates. Edgewise Therapeutics Inc (EWTX) shares have gone up 140.27% during the last six months, with a year-to-date growth rate less than the industry average at -12.10% against 12.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -68.02%. While earnings are projected to return -8.84% in 2024.
EWTX Dividends
Edgewise Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
